e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Obstructive sleep apnoea: clinical aspects I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Deregulation of carbohydrate metabolism in patients with sleep apnoea
J. Fernández-Lahera, F. García Río, I. Fernández, S. Zudaire, R. Casitas, C. Llontop, R. Galera, C. Villasante, R. Álvarez-Sala (Madrid, Spain)
Source:
Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Session:
Obstructive sleep apnoea: clinical aspects I
Session type:
Thematic Poster Session
Number:
2271
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Fernández-Lahera, F. García Río, I. Fernández, S. Zudaire, R. Casitas, C. Llontop, R. Galera, C. Villasante, R. Álvarez-Sala (Madrid, Spain). Deregulation of carbohydrate metabolism in patients with sleep apnoea. Eur Respir J 2011; 38: Suppl. 55, 2271
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
The role of hyaluronan metabolism in obstructive sleep apnoea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Diabetes and metabolic aspects of OSA
Source: Eur Respir Mon 2010; 50: 189-215
Year: 2010
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Disregulation of iron metabolism and atherosclerotic changes in Obstructive sleep apnoea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002
The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Ghrelin and impaired glucose tolerance in obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 666s
Year: 2005
Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea
Source: Eur Respir J 2011; 37: 1418-1423
Year: 2011
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
The puzzle of metabolic effects of obstructive sleep apnoea in children
Source: Eur Respir J 2016; 47: 1050-1053
Year: 2016
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: 156-160
Year: 2003
Erythrocyte glycolysis in severe obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
Exercise responses in patients with sleep apnoea
Source: Virtual Congress 2020 – Exercise and sleep: from impaired function to new therapeutic strategies
Year: 2020
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
APAP impact on metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept